TUESDAY, Nov. 19, 2024 (HealthDay News) — Japanese researchers say they have found a pill that works as well as existing medication to prevent blood clots after heart valve surgery, with fewer trips to the doctor. Unlike warfarin, the standard treatment, edoxaban does not require regular monitoring of blood clottingContinue Reading

THURSDAY, Sept. 25, 2024 (HealthDay News) — A new gene therapy approved earlier this year can serve as a sustainable single-dose treatment for people with hemophilia B, newly published clinical trial data shows. People with hemophilia B saw their bleeding episodes drop by an average 71% following a single infusionContinue Reading

TUESDAY, June 18, 2024 (HealthDay News) — There’s more good news in the battle against sickle cell disease, with another trial finding CRISPR gene-editing therapy delivering impressive results for patients. “It’s encouraging that this gene-editing treatment continues to show promising efficacy for sickle cell patients,” said study lead investigator Dr.Continue Reading